Advanced Search

column
Chinese Expert Consensus on Management of Thrombocytopenia in Cancer Patients with Liver Injury (2022 Edition)
Committee of Neoplastic Supportive-care (CONS), China Anti-Cancer Association
2023, 50(3): 211-223. DOI: 10.3971/j.issn.1000-8578.2023.23.0156
Abstract PDF
Primary Prevention of Ovarian Cancer
SHEN Li'na, ZANG Rongyu
2023, 50(3): 224-228. DOI: 10.3971/j.issn.1000-8578.2023.22.1176
Abstract PDF
Research Progress of 3D Printing Technology for Perioperative Treatment of Osteosarcoma
ZHANG Peng
2023, 50(3): 229-235. DOI: 10.3971/j.issn.1000-8578.2023.22.0944
Abstract PDF
miR-9500 Regulates Migration and Invasion of Lung Adenocarcinoma Cells by Targeting SMAD2
LI Fang, HAN Caili, WANG Li, SHEN Hui
2023, 50(3): 236-242. DOI: 10.3971/j.issn.1000-8578.2023.22.0826
Abstract PDF
MDM2 Inhibitor RG-7388 Promotes Apoptosis and Cell Cycle Arrest of Diffuse Large B Cell Lymphoma
ZHUANG Yan, HUANG Hao, ZHOU Junyi, PAN Ting, DING Xiaorong, YUAN Ying, ZHONG Xiaomin
2023, 50(3): 243-248. DOI: 10.3971/j.issn.1000-8578.2023.22.0873
Abstract PDF
Ferroptosis-related Recurrence Risk Model Predicts Clinical Outcomes and Immune Infiltration in Glioblastoma
LIAO Yongzhen, LIANG Lu, LI Yi, CONG Li
2023, 50(3): 249-257. DOI: 10.3971/j.issn.1000-8578.2023.22.0836
Abstract PDF
Treatment Strategies and Prognostic Factors in Patients with Stage T3 and T4 Laryngeal Carcinoma
LI Liang, CHEN Renjie, YU Zuhua
2023, 50(3): 258-263. DOI: 10.3971/j.issn.1000-8578.2023.22.0725
Abstract PDF
Prognostic Model Based on Preoperative FAR and SII Versus TNM Staging System in Evaluating Prognosis of Patients with Pancreatic Cancer After Radical Resection
LIU Xudong, ZHAO Bin, DU Peng, ZHANG Guoqiang, ZHENG Qiang, LAI Jiamin, CHENG Zhibin
2023, 50(3): 264-270. DOI: 10.3971/j.issn.1000-8578.2023.22.1090
Abstract PDF
Correlation Between Apparent Diffusion Coefficient and IDH-1/1p19q Genotype of Glioma
SUN Pengfei, MOU Fuling, MA Li, FU Zhengfeng
2023, 50(3): 271-275. DOI: 10.3971/j.issn.1000-8578.2023.22.0698
Abstract PDF
Construction of Prognostic Model for Cuprotosis in Hepatocellular Carcinoma Based on TCGA Database
LEI Qingsong, LI Lin
2023, 50(3): 276-282. DOI: 10.3971/j.issn.1000-8578.2023.22.0875
Abstract PDF
Clinical Characteristics of Chronic Myeloid Leukemia Patients with Deletion and Non-deletion of ASS Gene on Derivative Chromosome 9
GAO Guanlun, ZHOU Xuan, XU Na, LIU Xiaoli, WEI Ting, LI Qingshan
2023, 50(3): 283-287. DOI: 10.3971/j.issn.1000-8578.2023.22.0701
Abstract PDF
Clinical Observation of 32 Cases of Malignant Lymphoma Treated with Brentuximab Vedotin Combined with Chemotherapy
CHAI Xiaofei, QIAO Honghan, ZHANG Lei, LI Xin, LI Ling, WANG Xinhua, FU Xiaorui, ZHANG Xudong, SUN Zhenchang, NAN Feifei, ZHANG Mingzhi
2023, 50(3): 288-292. DOI: 10.3971/j.issn.1000-8578.2023.22.1235
Abstract PDF
A Real-world Study of Anti-PD-1 Antibody Combination Therapy in Advanced Hepatocellular Carcinoma
QIAO Shishi, KONG Tiandong, YU Dan, YANG Zhen, PAN Yanfeng, ZHAO Lingdi
2023, 50(3): 293-297. DOI: 10.3971/j.issn.1000-8578.2023.22.0852
Abstract PDF
Research Progress in Improving Efficacy of Radiotherapy by Targeting Glutamine Metabolism
QIAO Wanjia, DONG Na, LIU Xiaojun
2023, 50(3): 298-302. DOI: 10.3971/j.issn.1000-8578.2023.22.0788
Abstract PDF
Research Progress on Postoperative Adjuvant Therapy for Completely Resected Stage ⅠB Non-small Cell Lung Cancer
MA Shishi, DAI Yuran, CHEN Xiaopin
2023, 50(3): 303-308. DOI: 10.3971/j.issn.1000-8578.2023.22.0933
Abstract PDF
miR-155-5p Expression, Function and Regulation in Tumors
JIN Ruizhe, WANG Dixian, ZHAO Qian, LIU Tiejun
2023, 50(3): 309-315. DOI: 10.3971/j.issn.1000-8578.2023.22.1026
Abstract PDF
Current Status of Off-label Use of Denosumab in Bone Tumor and Bone Diseases
LI Ping, GUO Xu
2023, 50(3): 316-320. DOI: 10.3971/j.issn.1000-8578.2023.22.0860
Abstract PDF
Advances in Emerging Therapies for Multiple Myeloma
QIAN Chenjing, HONG Mei, XIA Linghui
2023, 50(3): 321-325. DOI: 10.3971/j.issn.1000-8578.2023.22.0874
Abstract PDF
Innovative "Toxicity Attenuation" Technology by the Chinese Team Will Benefit 99% of NPC Patients, etc
2023, 50(3): 326-326. DOI: 10.3971/j.issn.1000-8578.2023.03.0001
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：